Edition:
India

Bayer AG (BAYGn.DE)

BAYGn.DE on Xetra

57.22EUR
18 Sep 2020
Change (% chg)

€0.50 (+0.88%)
Prev Close
€56.72
Open
€56.83
Day's High
€57.70
Day's Low
€56.64
Volume
7,344,395
Avg. Vol
3,492,347
52-wk High
€78.34
52-wk Low
€44.85

Select another date:

Thu, Sep 17 2020

Photo

Exclusive: In the weeds - How Bayer, U.S. government teamed up against Thailand's glyphosate ban

BANGKOK Chemicals giant Bayer and the U.S. government cooperated closely last year to lobby Thailand to reverse its ban on glyphosate, used in the company's controversial weedkiller Roundup, documents obtained by an environmental group and reviewed by Reuters show.

In the weeds: How Bayer, U.S. government teamed up against Thailand's glyphosate ban

BANGKOK Chemicals giant Bayer and the U.S. government cooperated closely last year to lobby Thailand to reverse its ban on glyphosate, used in the company's controversial weedkiller Roundup, documents obtained by an environmental group and reviewed by Reuters show.

Bayer settles thousands of U.S. Roundup cases with trial attorneys

Bayer AG has settled thousands of U.S. Roundup weed killer lawsuits as part of an $11 billion settlement, reaching deals with the only lawyers who took cases to trial over allegations the herbicide caused cancer.

UPDATE 1-Bayer settles thousands of U.S. Roundup cases with trial attorneys

Sept 15 Bayer AG has settled thousands of U.S. Roundup weed killer lawsuits as part of an $11 billion settlement, reaching deals with the only lawyers who took cases to trial over allegations the herbicide caused cancer.

Bayer settles thousands of U.S. Roundup cases with trial attorneys

Sept 15 Bayer AG has settled thousands of U.S. Roundup weed killer lawsuits as part of an $11 billion settlement, reaching deals with the only lawyers who took cases to trial over allegations the herbicide caused cancer.

Bayer in deal with Systems Oncology over novel breast cancer drug

FRANKFURT Bayer said on Tuesday it had secured the rights to an experimental breast cancer drug developed by U.S. biotech firm Systems Oncology LLC in a deal worth up to $370 million.

Bayer in deal with Systems Oncology over novel breast cancer drug

FRANKFURT, Sept 15 Bayer said on Tuesday it had secured the rights to an experimental breast cancer drug developed by U.S. biotech firm Systems Oncology LLC in a deal worth up to $370 million.

UPDATE 3-Bayer CEO's term extended, makes progress on Roundup settlement

* Shares gain on prospect of resolution (Adds shares, investor comment)

Bayer appeals $20.5 million Roundup ruling to California Supreme Court

Bayer AG has asked California's Supreme Court to review a decision awarding $20.5 million to a groundskeeper who claimed the company's Roundup weedkiller caused his cancer, arguing the ruling was at odds with federal law and settled legal principles.

UPDATE 1-Bayer appeals $20.5 mln Roundup ruling to California Supreme Court

Sept 1 Bayer AG has asked California's Supreme Court to review a decision awarding $20.5 million to a groundskeeper who claimed the company's Roundup weedkiller caused his cancer, arguing the ruling was at odds with federal law and settled legal principles.

Select another date: